World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
22299
World Ranking
1904
National Ranking
928

Medicine

D-Index
76
Citations
22296
World Ranking
18748
National Ranking
9341

Overview

Albert F. LoBuglio is affiliated with the University of Alabama at Birmingham in the United States. Their research spans several interconnected fields, including Biochemistry, Genetics and Molecular Biology, as well as Medicine, with a focus on Cancer Research, Genetics, and Oncology as subfields.

The scientist's work frequently explores topics related to Breast Cancer Treatment Studies, the effects of Estrogen and related hormones, and the role of HER2/EGFR in cancer research.

A notable recent publication is titled "TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer," published in 2020 in Breast Cancer Research.

Frequent co-authors collaborating with Albert F. LoBuglio include:

  • Christos Vaklavas
  • Brian S. Roberts
  • Katherine E. Varley
  • Nancy U. Lin
  • Minetta C. Liu

They have published primarily in the venue Breast Cancer Research.

Best Publications

  • Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

    Ziegler Ej;Fisher Cj;Sprung Cl;Straube Rc

  • Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy

    Myron S. Czuczman;A. J. Grillo-López;C. A. White;M. Saleh

  • Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

    Albert F. Lobuglio;Richard H. Wheeler;John Trang;Amy Haynes

  • Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer

    Francisco Robert;Mark P. Ezekiel;Sharon A. Spencer;Ruby F. Meredith

  • Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man.

    Albert F. LoBuglio;Ramzi S. Cotran;James H. Jandl

  • Characterization of a messenger RNA polynucleotide vaccine vector

    R. M. Conry;A. F. LoBuglio;M. Wright;L. Sumerel

  • Human immune response to monoclonal antibodies.

    M. B. Khazaeli;Robert M. Conry;Albert F. LoBuglio

  • Human Blood Monocytes: Stimulators of Granulocyte and Mononuclear Colony Formation in vitro

    Unknown

  • Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers

    James A. Bonner;Kevin P. Raisch;Hoa Q. Trummell;Francisco Robert

  • A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer.

    James A. Posey;M. B. Khazaeli;Alma DelGrosso;Mansoor N. Saleh

  • The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3 *

    Merideth C. Kamradt;Merideth C. Kamradt;Meiling Lu;Michael E. Werner;Toni Kwan

  • Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors

    Mansoor N. Saleh;Steve Sugarman;James Murray;Joy B. Ostroff

  • Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.

    Ashka Y. Pandya;Lynya I. Talley;Andra R. Frost;Thomas J. Fitzgerald

  • Immune Response to a Carcinoembryonic Antigen Polynucleotide Vaccine

    Robert M. Conry;Albert F. LoBuglio;Judith Kantor;Jeffrey Schlom

  • Effects of Corticosteroids on Human Monocyte Function

    Unknown

  • Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.

    Donald J. Buchsbaum;Tong Zhou;William E. Grizzle;Patsy G. Oliver

  • Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.

    Ronald D. Alvarez;Edward E. Partridge;M.B. Khazaeli;Gene Plott

  • Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.

    Mansoor N. Saleh;M. B. Khazaeli;Richard H. Wheeler;Edward Dropcho

  • A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

    R M Conry;A F LoBuglio;F Loechel;S E Moore

  • A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.

    Mansoor N. Saleh;John Gutheil;Melvin Moore;Patty W. Bunch

  • Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.

    Feng Wang-Johanning;Andra R. Frost;Gary L. Johanning;M. B. Khazaeli

  • Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A

    Henry Q. Xiong;Arthur Rosenberg;Albert LoBuglio;William Schmidt

Frequent Co-Authors

William E. Grizzle
William E. Grizzle University of Alabama at Birmingham
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
David T. Curiel
David T. Curiel Washington University in St. Louis
Ronald D. Alvarez
Ronald D. Alvarez Vanderbilt University Medical Center
Robert P. Kimberly
Robert P. Kimberly University of Alabama at Birmingham
William J. Koopman
William J. Koopman University of Alabama at Birmingham
Tong Zhou
Tong Zhou University of Alabama at Birmingham
Kirby I. Bland
Kirby I. Bland University of Alabama at Birmingham
George M. Shaw
George M. Shaw University of Pennsylvania
Richard M. Myers
Richard M. Myers HudsonAlpha Institute for Biotechnology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in exploring healthcare pathways related to immunology, nursing offers accessible and versatile options. Many students begin by looking into lpn schools easy to get into, which provide foundational knowledge and clinical experience. These programs often serve as a stepping stone to more advanced roles in healthcare.

Nurse practitioners (NPs) specializing in immunology-related fields are in high demand, particularly in mental health and chronic disease management. Prospective students can consider programs known for being the easiest NP program options to help fast-track their education. This flexibility allows learners to balance studies with clinical work effectively.

Online programs for psychiatric nurse practitioners, such as online pmhnp programs with clinical placement, offer valuable hands-on experience in clinical settings. Clinical placements are critical for integrating theory with practice, especially in fields requiring patient interaction.

Cost is another important factor; thus, students often seek the cheapest psych NP programs online to ensure education remains financially accessible while maintaining quality. Affordable programs can significantly reduce student debt and improve career entry opportunities.

Best Scientists Citing Albert F. LoBuglio

Trending Scientists